News Headline Summary

Telik's (TELK) Telintra get orphan drug designation from the FDA

Reaction details (18:04)

- In an immediate reaction; co.'s shares moved 23% higher from USD 1.54 to USD 1.90.

11 Jan 2013 - 18:03 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: